2nd Quarter - Amendment

COVE STRATEGIES for THE MEDICINES COMPANY

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report Jul 20, 2011 $40,000 Replaced
2nd Quarter - Amendment (this page) Jan 19, 2012 $60,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

HR 1249, America Invests Act: issues relating to filing deadline under the Hatch-Waxman Act for patent term restorations. H. Amdt 499: Amendment clarifies the deadline for filing patent term extension applications covering drug products that must be approved by the FDA.

LobbyistCovered position, as disclosed
FRANK SADLER —
MATTHEW SCHLAPP —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1249 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.